SCHEMBL24343191

SCHEMBL24343191

c1ccc2c(c1)sc1ccc(-c3c4ccccc4c(-c4ccc5sc6cc7c(ccc8sc9ccccc9c87)cc6c5c4)c4ccccc34)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.40
MAPT P10636 6/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
DUSP3 P51452 2/20 0.37
MEN1 O00255 1/20 0.37
BLM P54132 1/20 0.37
PTPN5 P54829 1/20 0.37
KMT2A Q03164 1/20 0.37
PTPN11 Q06124 1/20 0.37
MCL1 Q07820 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37
NQO1 P15559 1/20 0.35
NQO2 P16083 1/20 0.35
PTPN1 P18031 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19110323 0.96 MAPT (0.41) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL24341027 0.93 MAPT (0.35) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL19109108 0.93 NQO2 (0.43) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL24342087 0.92 NQO1 (0.35) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL24341038 0.92 MAPT (0.38) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL19110331 0.92 MAPT (0.40) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL19109251 0.91 CYP1A2 (0.34) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL24341075 0.91 ESR1 (0.35) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL19123860 0.91 ESR1 (0.35) GPR3MAPTALDH1A1HPGDRAB9A
SCHEMBL19123896 0.91 ESR1 (0.36) GPR3MAPTALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 GPR3 3219/4885MAPT 1538/4885ALDH1A1 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.